US Interventional Cardiology Market 2025 | Growth Drivers & Investment Opportunities

Market Size and Growth

The US Interventional Cardiology Market size reached US$ 6.37 billion in 2024 and is expected to reach US$ 10.81 billion by 2033, growing at a CAGR of 6.1% during the forecast period of 2025-2033.

Key Development:

United States: Recent Industry Developments

✅ In July 2025, InspireMD launched the CGuard Prime carotid stent system in the U.S. following FDA PMA approval. The device uses a dual‐layer design (mesh + open‐cell frame) to trap emboli and protect against stroke, with "SmartFit" tech for vessel wall apposition.

✅ In May 2025, Terumo Interventional Systems introduced the Roadsaver carotid stent system in a limited U.S. market release (with full release planned by fall). This dual‐layer micromesh stent works with Terumo's Nanoparasol protection system and is indicated for carotid artery stenosis in patients at high risk from endarterectomy.

✅ In May 2025, Reflow Medical's Spur Peripheral Retrievable Stent System obtained the FDA's de novo classification. It features expandable spikes and is designed for treatment of infrapopliteal arterial disease (below‐the‐knee, CLTI), offering a novel option for complex peripheral lesions.

✅ In May 2025, Boston Scientific received FDA approval for its TAXUS Liberte Atom Drug‐Eluting Stent System, designed for treating small coronary vessels (as small as ~2.25 mm diameter). It offers improved deliverability and conformability over previous systems, aiming to reduce target lesion revascularization in small vessels.

✅ In 2025 (recent), Teleflex completed the acquisition of BIOTRONIK's Vascular Intervention business, expanding its portfolio to include drug‐coated balloons, drug‐eluting stents, and covered stents. This strengthens Teleflex's position in the interventional cardiology & peripheral market.

Japan: Recent Industry Developments

✅ In August 2025, the ParadiseTM Ultrasound Renal Denervation (uRDN) System received manufacturing and marketing approval in Japan for treating resistant hypertension. This is the first device approved in Japan indicated specifically for this disease, based on RADIANCE‐HTN TRIO trial data.

✅ In May 2025, iVascular and Medico's Hirata launched the Luminor 18 RX Drug‐Coated Balloon in Japan, a rapid‐exchange version tailored for Japanese regulatory/clinical environment. The product is meant to improve outcomes in peripheral vascular interventions informed by the SOL‐Japan trial.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/us-interventional-cardiology-market?sb

US Interventional Cardiology Market refers to the sector focused on minimally invasive procedures to diagnose and treat cardiovascular diseases, such as angioplasty, stenting, and catheter-based interventions. The market includes devices like stents, balloons, guidewires, catheters, and imaging systems. Growth in the US market is driven by increasing prevalence of cardiovascular diseases, technological advancements, rising geriatric population, and preference for less invasive treatment options that reduce recovery time and improve patient outcomes.

Key Players:

-> Medtronic PLC, TERUMO CORPORATION, Boston Scientific Corporation, Abbott Laboratories, Canon Medical Systems Corporation, Teleflex Incorporated, B. Braun SE, Johnson & Johnson Services, Inc., Koninklijke Philips N.V and Cook Medical among others.

Growth Forecast Projected:

The Global US Interventional Cardiology Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2033. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global US Interventional Cardiology Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=us-interventional-cardiology-market

Key Segments:

By Type: Stents, Balloons, Guidewires, Closure Devices, Catheters, Atherectomy Systems, Thrombectomy Systems, Imaging Systems, Chronic Total Occlusion Systems (CTO), Others

By End-User: Hospitals, Ambulatory Surgical Centers, CATH Labs, Others

Regional Analysis for US Interventional Cardiology Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among US Interventional Cardiology producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze US Interventional Cardiology revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/us-interventional-cardiology-market?sb

FAQ

What is the current size of the US Interventional Cardiology Market?

A: In 2024, the US Interventional Cardiology Market was valued at US$ 6.37 billion, reflecting its strong industry presence.

Q2: How large is the US Interventional Cardiology Market expected to be by 2033?

A: By 2033, industry forecasts suggest the US Interventional Cardiology Market will grow to around US$ 10.81 billion , demonstrating significant expansion.

Q3: What is the growth rate of the US Interventional Cardiology Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 6.1% during the forecast period from 2025 to 2033.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.